{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T02:37:39Z","timestamp":1769049459177,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00392-025-02739-9","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T14:37:54Z","timestamp":1757342274000},"page":"313-321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prescription of lipid-lowering drugs and their association with hospitalization for ST-elevation myocardial infarction (STEMI) in Germany in 2010\u20132022"],"prefix":"10.1007","volume":"115","author":[{"given":"Knut","family":"Kr\u00f6ger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"Wiemes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans","family":"Santosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hinrich","family":"B\u00f6hner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hildegard","family":"Lax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Stolpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Kowall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Stang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"2739_CR1","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM et al (2021) 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 42:3227\u20133337","journal-title":"Eur Heart J"},{"key":"2739_CR2","unstructured":"Cardiovascular disease: risk assessment and reduction, including lipid modification NICE guideline Published: 14 December 2023 www.nice.org.uk\/guidance\/ng238"},{"key":"2739_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3949\/ccjm.87a.19078","volume":"87","author":"C Reiter-Brennan","year":"2020","unstructured":"Reiter-Brennan C, Osei AD, Iftekhar Uddin SMI, Orimoloye OA, Obisesan OH, Mirbolouk M, Blaha MJ, Dzaye O (2020) ACC\/AHA lipid guidelines: personalized care to prevent cardiovascular disease. Cleve Clin J Med 87:231\u2013239","journal-title":"Cleve Clin J Med"},{"key":"2739_CR4","doi-asserted-by":"crossref","unstructured":"Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corra U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Lochen ML, Lollgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM, Binno S, ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 37:23152381","DOI":"10.1093\/eurheartj\/ehw106"},{"key":"2739_CR5","doi-asserted-by":"crossref","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner \u017d, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WMM, Vlachopoulos C, Wood DA, Zamorano JL, Cooney MT; ESC Scientific Document Group. 2016\u00a0ESC\/EAS\u00a0Guidelines\u00a0for the Management of\u00a0Dyslipidaemias. Eur Heart J 37:2999-3058","DOI":"10.1093\/eurheartj\/ehw272"},{"issue":"1","key":"2739_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O, ESC Scientific Document Group (2020) 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 41(1):111\u2013188","journal-title":"Eur Heart J"},{"key":"2739_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.912785","volume":"9","author":"JL Katzmann","year":"2022","unstructured":"Katzmann JL, Kieble M, Enners S, B\u00f6hm M, Mahfoud F, Laufs U, Schulz M (2022) Trends in ezetimibe prescriptions as monotherapy or fixed-dose combination in Germany 2012\u20132021. Front Cardiovasc Med 9:912785","journal-title":"Front Cardiovasc Med"},{"key":"2739_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00392-020-01740-8","volume":"111","author":"JL Katzmann","year":"2022","unstructured":"Katzmann JL, Sorio-Vilela F, Dornstauder E, Fraas U, Smieszek T, Zappacosta S, Laufs U (2022) Non-statin lipid-lowering therapy over time in very-high-risk patients: effectiveness of fixed-dose statin\/ezetimibe compared to separate pill combination on LDL-C. Clin Res Cardiol 111:243\u2013252","journal-title":"Clin Res Cardiol"},{"key":"2739_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10654-010-9543-4","volume":"26","author":"A Stang","year":"2011","unstructured":"Stang A, Merrill RM, Ku\u00df O (2011) Nationwide rates of conversion from laparoscopic or vaginal hysterectomy to open abdominal hysterectomy in Germany. Eur J Epidemiol 26:125\u2013133","journal-title":"Eur J Epidemiol"},{"key":"2739_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10654-013-9816-9","volume":"28","author":"A Stang","year":"2013","unstructured":"Stang A, K\u00e4\u00e4b-Sanyal V, Hense HW, Becker N, Kuss O (2013) Effect of mammography screening on surgical treatment for breast cancer: a nationwide analysis of hospitalization rates in Germany 2005\u20132009. Eur J Epidemiol 28:689\u2013696","journal-title":"Eur J Epidemiol"},{"key":"2739_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-055015","volume":"12","author":"M Danese","year":"2022","unstructured":"Danese M, Sidelnikov E, Villa G, Catterick D, Iqbal M, Gleeson M, Lubeck D, Patel J (2022) Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UK. BMJ Open 12:e055015","journal-title":"BMJ Open"},{"key":"2739_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.23736\/S0031-0808.22.04777-2","volume":"65","author":"P Sabouret","year":"2023","unstructured":"Sabouret P, Puymirat E, Kownator S, Abdennbi K, Lebeau F, Meltz M, Angoulvant D, Schiele F (2023) Lipid-lowering treatment up to one year after acute coronary syndrome: guidance from a French expert panel for the implementation of guidelines in practice. Panminerva Med 65:244\u2013249","journal-title":"Panminerva Med"},{"issue":"3","key":"2739_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/eurheartj\/ehaa1011","volume":"42","author":"J Schubert","year":"2021","unstructured":"Schubert J, Lindahl B, Melhus H, Renlund H, Leosdottir M, Yari Ai, Ueda P, Jernberg T, Hagstr\u00f6m E (2021) Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study. Eur Heart J 42(3):243\u2013252","journal-title":"Eur Heart J"},{"key":"2739_CR14","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/eurjpc\/zwaa047","volume":"28","author":"KK Ray","year":"2021","unstructured":"Ray KK, Molemans B, Schoonen WM, Giovas P, Bray S, Kiru G, Murphy J, Banach M, De Servi S, Gaita D, Gouni-Berthold I, Hovingh GK, Jozwiak JJ, Jukema JW, Kiss RG, Kownator S, Iversen HK, Maher V, Masana L, Parkhomenko A, Peeters A, Clifford P, Raslova K, Siostrzonek P, Romeo S, Tousoulis D, Vlachopoulos C, Vrablik M, Catapano AL, Poulter NR, DA VINCI study (2021) EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study. Eur J Prev Cardiol 28:1279\u20131289","journal-title":"Eur J Prev Cardiol"},{"key":"2739_CR15","unstructured":"Cannon CP, de Lemos JA, Rosenson RS, Ballantyne CM, Liu Y, Gao Q, Palagashvilli T, Alam S, Mues KE, Bhatt DL, Kosiborod MN; GOULD Investigators (2021) Use of lipid-lowering therapies over 2 years in GOULD, a registry of patients with atherosclerotic cardiovascular disease in the US. JAMA Cardiol 6(9):1060\u20131068"},{"key":"2739_CR16","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1016\/j.atherosclerosissup.2021.01.009","volume":"42","author":"U Landmesser","year":"2020","unstructured":"Landmesser U, Pirillo A, Farnier M, Jukema JW, Laufs U, Mach F, Masana L, Pedersen TR, Schiele F, Steg G, Tubaro M, Zaman A, Zamorano P, Catapano AL (2020) Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: the ACS patient pathway project. Atheroscler Suppl 42:e49-58","journal-title":"Atheroscler Suppl"},{"key":"2739_CR17","doi-asserted-by":"publisher","first-page":"114638","DOI":"10.1016\/j.envres.2022.114638","volume":"216","author":"T Burkhardt","year":"2023","unstructured":"Burkhardt T, Scherer M, Scherer G, Pluym N, Weber T, MarikeKolossa-Gehring M (2023) Time trend of exposure to secondhand tobacco smoke and polycyclic aromatic hydrocarbons between 1995 and 2019 in Germany - showcases for successful European legislation. Environ Res 216:114638","journal-title":"Environ Res"},{"key":"2739_CR18","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1159\/000525792","volume":"15","author":"C Stival","year":"2022","unstructured":"Stival C, Lugo A, Odone A, van den Brandt PA, Fernandez E, Tigova O, Soriano JB, L\u00f3pez MJ, Scaglioni S, Gallus S (2022) TackSHS project investigators prevalence and correlates of overweight and obesity in 12 European countries in 2017-2018. Obes Facts 15:655\u2013665","journal-title":"Obes Facts"},{"issue":"10263","key":"2739_CR19","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0140-6736(20)32332-1","volume":"396","author":"B Gencer","year":"2020","unstructured":"Gencer B, Marston NA, Im K, Cannon CP, Sever P, Keech A, Braunwald E, Giugliano RP, Sabatine MS (2020) Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials. Lancet 396(10263):1637\u20131643","journal-title":"Lancet"},{"key":"2739_CR20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1253\/circj.CJ-19-0859","volume":"84","author":"T Sato","year":"2020","unstructured":"Sato T, Minami Y, Asakura K, Katamine M, Kato A, Katsura A, Muramatsu Y, Kakizaki R, Nemoto T, Hashimoto T, Fujiyoshi K, Kameda R, Meguro K, Shimohama T, Ako J (2020) Age- and gender-related differences in coronary lesion plaque composition on optical coherence tomography. Circ J 84:463\u2013470","journal-title":"Circ J"},{"key":"2739_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.031474","volume":"12","author":"K Suzuki","year":"2023","unstructured":"Suzuki K, Niida T, Yuki H, Kinoshita D, Fujimoto D, Lee H, McNulty I, Takano M, Nakamura S, Kakuta T, Mizuno K, Jang IK (2023) Coronary plaque characteristics and underlying mechanism of acute coronary syndromes in different age groups of patients with diabetes. J Am Heart Assoc 12:e031474","journal-title":"J Am Heart Assoc"},{"key":"2739_CR22","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.hlc.2021.11.014","volume":"31","author":"L Nedkoff","year":"2022","unstructured":"Nedkoff L, Lopez D, Hung J, Knuiman M, Briffa TG, Murray K, Davis E, Aria S, Robinson K, Beilby J, Hobbs MST, Sanfilippo FM (2022) Validation of ICD-10-AM coding for myocardial infarction subtype in hospitalisation data. Heart Lung Circ 31:849\u2013858","journal-title":"Heart Lung Circ"},{"key":"2739_CR23","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s00392-023-02257-6","volume":"113","author":"W Koenig","year":"2024","unstructured":"Koenig W, Lorenz ES, Beier L, Gouni-Berthold I (2024) Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany. Clin Res Cardiol 113:812\u2013821","journal-title":"Clin Res Cardiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02739-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-025-02739-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02739-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:38:11Z","timestamp":1768995491000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-025-02739-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2739"],"URL":"https:\/\/doi.org\/10.1007\/s00392-025-02739-9","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"assertion":[{"value":"19 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval is not available. According to the professional code for physicians in North Rhine-Westphalia, retrospective epidemiological research projects are excluded from the requirement of an ethics vote.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"K. Kr\u00f6ger has received speaker\u2019s fees from Amgen. The other authors do not have any conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}